Cyclooxygenase-2 polymorphisms were associated with the risk of gastric cancer: Evidence from a meta-analysis based on case-control studies

Tumor Biology

Volumn 34, Issue 6, 2013, Pages 3323-3330

  Yan, Wen Feng ^a   Sun, Pei Chun ^a   Nie, Chang Fu ^a   Wu, Gang ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; Gastric cancer; Meta analysis; Polymorphism

Indexed keywords

CYCLOOXYGENASE 2;

ALLELE; ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; ENZYME POLYMORPHISM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; PRIORITY JOURNAL; STOMACH CANCER;

EID: 84891484386     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0901-1     Document Type: Article

References (36)

1. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893-907.
2. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12:17-20.
3. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010;102:1344-53.
4. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol. 2007;102:1789-98.
5. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291:187-94.
6. Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, et al. P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer. 2007;121:1481-6.
7. Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, et al. Interleukin-10-1082 promoter polymorphism associated with gastric cancer among Asians. Eur J Cancer. 2008;44:2648-54.
8. Da MX, Wu XT, Wang J, Guo TK, Zhao ZG, Luo T, et al. Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer. Arch Med Res. 2008;39:92-9.
9. Yeh TS, Wu CW, Hsu KW, Liao WJ, Yang MC, Li AF, et al. The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res. 2009;69:5039-48.
10. Shin WG, Kim HJ, Cho SJ, Kim HS, Kim KH, Jang MK, et al. The COX-2-1195AA genotype is associated with diffuse-type gastric cancer in Korea. Gut Liver. 2012;6:321-7.
11. Zhang XM, Zhong R, Liu L, Wang Y, Yuan JX, Wang P, et al. Smoking and COX-2 functional polymorphisms interact to increase the risk of gastric cardia adenocarcinoma in Chinese population. PLoS One. 2011;6:e21894.
12. Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56:297-303.
13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
14. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
15. Liu F, Pan K, Zhang X, Zhang Y, Zhang L, Ma J, et al. Genetic variants in cyclooxygenase-2: expression and risk of gastric cancer and its precursors in a Chinese population -765G>C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. Gastroenterology. 2006;130:1975-84.
16. Pereira C, Sousa H, Ferreira P, Fragoso M, Moreira-Dias L, Lopes C, et al. -765G>C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. World J Gastroenterol. 2006;12:5473-8.
17. Zhang XM, Xiao XP, Tan W, Sun T, Guo YL, Zhao D, et al. Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006;28:119-23.
18. Hou L, Grillo P, Zhu ZZ, Lissowska J, Yeager M, Zatonski W, et al. COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population. Anticancer Res. 2007;27:4243-7.
19. Jiang GJ, Wang HM, Zhou Y, Tan YF, Ding WL, Guo J, et al. The correlation study between the nucleotide polymorphisms of cyclooxygenase-2 gene and the susceptibility to gastric cancer. Acta Univ Med Nanjing. 2007;27:890-4.
20. Saxena A, Prasad KN, Ghoshal UC, Bhagat MR, Krishnani N, Husain N. Polymorphism of -765G>C COX-2 is a risk factor for gastric adenocarcinoma and peptic ulcer disease in addition to H. pylori infection: a study from northern India. World J Gastroenterol. 2008;14:1498-503.
21. Sitarz R, Leguit RJ, de Leng WW, Polak M, Morsink FM, Bakker O, et al. The COX-2 promoter polymorphism -765G>C is associated with early-onset, conventional and stump gastric cancers. Mod Pathol. 2008;21:685-90.
22. Tang XF, Li YM, Li SX, Li X, He WT, Zhang D, et al. Correlation between the nucleotide polymorphisms of cox-2 and the susceptibility to gastric cancer in Hui ethnic group. Shi Jie Hua Ren Xiao Hua Za Zhi. 2009;17:1772-6.
23. Ke-Xiang Z, Yu-Min L, Xun L, Wen-Ce Z, Yong S, Tao L. Study on the association of COX-2 genetic polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu province in China. Mol Biol Rep. 2011;38:649-55.
24. Li Y, Dai L, Zhang J, Wang P, Chai Y, Ye H, et al. Cyclooxygenase-2 polymorphisms and the risk of gastric cancer in various degrees of relationship in the Chinese Han population. Oncol Lett. 2012;3:107-12.
25. Boccia S, De Feo E, Galli P, Gianfagna F, Amore R, Ricciardi GA. Systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research. Eur J Epidemiol. 2010;25:765-75.
26. Szczeklik W, Sanak M, Szczeklik A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol. 2004;114:248-53.
27. Pereira C, Medeiros RM, Dinis-Ribeiro MJ. Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available? Eur J Gastroenterol Hepatol. 2009;21:76-91.
28. Brzozowski T, Konturek PC, Konturek SJ, Pajdo R, Schuppan D, Drozdowicz D, et al. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor. J Physiol Pharmacol. 2000;51:751-73.
29. Uefuji K, Ichikura T, Mochizuki H. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res. 2000;6:135-8.
30. Chen CN, Hsieh FJ, Cheng YM, Chang KJ, Lee PH. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer. J Surg Oncol. 2006;94:226-33.
31. Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology. 2005;129:565-76.
32. Oshima H, Oshima M. The role of PGE2-associated inflammatory responses in gastric cancer development. Semin Immunopathol. 2013;35:139-50.
33. Liang Y, Liu JL, Wu Y, Zhang ZY, Wu R. Cyclooxygenase-2 polymorphisms and susceptibility to esophageal cancer: a meta-analysis. Tohoku J Exp Med. 2011;223:137-44.
34. Bu X, Zhao C. The association between cyclooxygenase-2 1195 G/A polymorphism and hepatocellular carcinoma: evidence from a meta-analysis. Tumour Biol. 2013;34(3):1479-84. doi: 10.1007/s13277-013-0672-8. Epub 2013 Mar 14.
35. Hoff JH, te Morsche RH, Roelofs HM, van der Logt EM, Nagengast FM, Peters WH. COX-2 polymorphisms -765G->C and -1195A->G and colorectal cancer risk. World J Gastroenterol. 2009;15:4561-5.
36. Liu F, Liu L, Li B, Wei YG, Yan LN, Wen TF, et al. p73 G4C14-A4T14 polymorphism and cancer risk: a meta-analysis based on 27 case-control studies. Mutagenesis. 2011;26:573-81.